3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Ependymoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
selpercatinib
2
dabrafenib
2
Sorafenib
2
Fluorodeoxyglucose F18
2
AZD 6244
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tovorafenib
1
tanespimycin
1
romidepsin
1
pralsetinib
1
pembrolizumab
1
omipalisib
1
durvalumab
1
copanlisib
1
cediranib
1
alectinib
1
aflibercept
1
Vorinostat
1
Vemurafenib
1
Thyrotropin Alfa
1
Thyroidectomy
1
Thyroid (USP)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Cancer, Papillary
×
Ritonavir
×
Clear all
No trials found.